Drug Patent Expirations for the Week of August 8, 2021

CAPRELSA (vandetanib) Genzyme corp Patent: 7,173,038 Expiration: Aug 14, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Pate…


New patent for Sunovion Pharms drug KYNMOBI

Annual Drug Patent Expirations for KYNMOBI Kynmobi is a drug marketed by Sunovion Pharms Inc and is included in one NDA. There are seventeen patents protecting this drug. Drug patent…
The post New patent for Sunovion Pharms drug KYNMOBI appeared first …


Biotechblog